The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Inspire Medical Systems Inc (NYSE: INSP) was $129.70 for the day, up 1.93% from the previous closing price of $127.25. In other words, the price has increased by $1.93 from its previous closing price. On the day, 0.59 million shares were traded. INSP stock price reached its highest trading level at $132.3 during the session, while it also had its lowest trading level at $126.01.
Ratios:
Our analysis of INSP’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.36 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 48.51. For the most recent quarter (mrq), Quick Ratio is recorded 7.44 and its Current Ratio is at 9.01. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on November 20, 2024, Upgraded its rating to Buy and sets its target price to $255 from $220 previously.
On May 08, 2024, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $265 to $225.
On April 19, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $285.RBC Capital Mkts initiated its Outperform rating on April 19, 2024, with a $285 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 19 ’25 when Rondoni John sold 1,734 shares for $149.38 per share. The transaction valued at 259,025 led to the insider holds 13,766 shares of the business.
JOHN RONDONI bought 1,734 shares of INSP for $259,025 on May 19 ’25. On May 02 ’25, another insider, mcCormick Shawn, who serves as the Director of the company, sold 360 shares for $160.00 each. As a result, the insider received 57,600 and left with 24,046 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 3825358848 and an Enterprise Value of 3489696000. As of this moment, Inspire’s Price-to-Earnings (P/E) ratio for their current fiscal year is 59.77, and their Forward P/E ratio for the next fiscal year is 40.09. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.68. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.55 while its Price-to-Book (P/B) ratio in mrq is 6.01. Its current Enterprise Value per Revenue stands at 4.154 whereas that against EBITDA is 59.581.
Stock Price History:
The Beta on a monthly basis for INSP is 1.29, which has changed by -0.22664124 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $225.00, while it has fallen to a 52-week low of $123.00. The 50-Day Moving Average of the stock is -11.34%, while the 200-Day Moving Average is calculated to be -27.21%.
Shares Statistics:
INSP traded an average of 504.59K shares per day over the past three months and 606450 shares per day over the past ten days. A total of 29.47M shares are outstanding, with a floating share count of 27.62M. Insiders hold about 6.36% of the company’s shares, while institutions hold 111.39% stake in the company. Shares short for INSP as of 1748563200 were 3203372 with a Short Ratio of 6.35, compared to 1745971200 on 2866393. Therefore, it implies a Short% of Shares Outstanding of 3203372 and a Short% of Float of 14.6.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
